98 related articles for article (PubMed ID: 7915875)
1. Activated and regulatory T lymphocyte populations in chronic hemodialysis patients.
Rabb H; Agosti SJ; Pollard S; Bittle PA; Ramirez G
Am J Kidney Dis; 1994 Sep; 24(3):443-52. PubMed ID: 7915875
[TBL] [Abstract][Full Text] [Related]
2. Analysis of peripheral blood lymphocyte cell surface density of functional and activation associated markers in young and old hemodialysis patients.
Shabtai M; Avigad I; Schachter P; Czerniak A; Judich A; Ayalon A
J Urol; 1993 Nov; 150(5 Pt 1):1369-74. PubMed ID: 8411402
[TBL] [Abstract][Full Text] [Related]
3. [Change of T lymphocyte and its activated subsets in SARS patients].
Yu XY; Zhang YC; Han CW; Wang P; Xue XJ; Cong YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):542-6. PubMed ID: 14650154
[TBL] [Abstract][Full Text] [Related]
4. [Changes in lymphocyte receptors and their activation markers during hemodialysis using various membranes].
Rasic S; Dzemidzic J; Leto E; Resic H; Uncanin S
Med Arh; 2001; 55(4):221-3. PubMed ID: 11769450
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory, degenerative and vascular lesions in long-term dialysed patients.
Vrabie CD; Petrescu A; Waller M; Cojocaru M; Ciocâlteu A; Dina I
Rom J Intern Med; 2009; 47(2):149-59. PubMed ID: 20067165
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
7. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells.
Nguyen XD; Eichler H; Dugrillon A; Piechaczek C; Braun M; Klüter H
J Immunol Methods; 2003 Apr; 275(1-2):57-68. PubMed ID: 12667670
[TBL] [Abstract][Full Text] [Related]
9. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.
Ueki Y; Nagata M; Miyake S; Tominaga Y
J Clin Immunol; 1993 Jul; 13(4):279-87. PubMed ID: 7901232
[TBL] [Abstract][Full Text] [Related]
11. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Heleniak Z; Bryl E; Witkowski JM
J Clin Immunol; 2012 Feb; 32(1):189-200. PubMed ID: 21993694
[TBL] [Abstract][Full Text] [Related]
12. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
Chadburn A; Inghirami G; Knowles DM
Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
[TBL] [Abstract][Full Text] [Related]
13. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
[TBL] [Abstract][Full Text] [Related]
14. No effect of transfusion transmitted virus viremia on the distribution and activation of peripheral lymphocytes in hemodialyzed patients.
Fodor B; Ladányi E; Aleksza M; Takács M; Lakos G; Arkossy O; Koós A; Nagy A; Széll J; Klenk N; Sárváry E; Sipka S
Nephron; 2002 Dec; 92(4):933-7. PubMed ID: 12399644
[TBL] [Abstract][Full Text] [Related]
15. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
Baker C; Chang L; Elsegood KA; Bishop AJ; Gannon DH; Narendran P; Leech NJ; Dayan CM
Clin Exp Immunol; 2007 Mar; 147(3):472-82. PubMed ID: 17302896
[TBL] [Abstract][Full Text] [Related]
16. Haemodialysis in Diabetic Patients Modulates Inflammatory Cytokine Profile and T Cell Activation Status.
Almeida A; Lourenço O; Fonseca AM
Scand J Immunol; 2015 Aug; 82(2):135-41. PubMed ID: 25969863
[TBL] [Abstract][Full Text] [Related]
17. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
Meier P; Dayer E; Ronco P; Blanc E
Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
[TBL] [Abstract][Full Text] [Related]
19. T cell activation and disease severity in HIV infection.
Mahalingam M; Peakman M; Davies ET; Pozniak A; McManus TJ; Vergani D
Clin Exp Immunol; 1993 Sep; 93(3):337-43. PubMed ID: 8103715
[TBL] [Abstract][Full Text] [Related]
20. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
